Quantitative evaluation of 2-Deoxy-2[F-18]fluoro-D-glucose-Positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation

Molecular Imaging and Biology

Volumn 9, Issue 3, 2007, Pages 135-143

  Salem, Nicolas ^a   MacLennan, Gregory T ^b   Kuang, Yu ^a   Anderson, Paul W ^a   Schomisch, Steve J ^b   Tochkov, Ilia A ^c   Tennant, Bud C ^c   Lee, Zhenghong ^a,b  

^a Case Western Reserve University   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

FDG PET; Hepatocellular carcinoma; Kinetic modeling; Marmota monax; Woodchuck hepatitis virus

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; LIVER CELL CARCINOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE SECTION; TRANSPORT KINETICS; TUMOR DIFFERENTIATION; WOODCHUCK;

ANIMALS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEPATITIS B VIRUS, WOODCHUCK; LIVER NEOPLASMS, EXPERIMENTAL; MARMOTA; MODELS, STATISTICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

ANIMALIA; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

EID: 34248176916     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-007-0092-5     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, et al. (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
2. Merle P (2005) Epidemiology, natural history and pathogenesis of hepatocellular carcinoma. Cancer Radiother 9:452-457
3. Donato F, Tagger A, Gelatti U, et al. (2002) Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323-331
4. Peers FG, Gilman GA, Linsell CA (1976) Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer 17:167-176
5. Yeh FS, Yu MC, Mo CC, et al. (1989) Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49:2506-2509
6. Tremolda F, Benevegnu L, Drago C, et al. (1989) Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Hepatogastroenterology 36:519-521
7. Teefey SA, Hildeboldt CC, Dehdashti F, et al. (2003) Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET. Radiology 226:533-542
8. Kudo M, Tomita S, Tochio H, et al. (1992) Small hepatocellular carcinoma: Diagnosis with US angiography with intraarterial CO 2 microbubbles. Radiology 182:155-160
9. Nguyen MH, Garcia RT, Simpson PW, et al. (2002) Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 36:410-417
10. Cedrone A, Covino M, Caturelli E, et al. (2000) Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: Does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 47:1654-1658
11. Choi D, Kim SH, Lim JH, et al. (2001) Detection of hepatocellular carcinoma: Combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography. J Comput Assist Tomogr 25:777-785
12. Tang Y, Yamashita Y, Arakawa A, et al. (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172:1547-1554
13. Fujita T, Ito K, Honjo K, et al. (1999) Detection of hepatocellular carcinoma: Comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil. J Magn Reson Imaging 9:274-279
14. Krinsky G (2004) Magnetic resonance imaging of hepatocellular carcinoma. Proceedings of the NIH Workshop on hepatocellular carcinoma: Screening, diagnosis, and management. 103-108
15. Jeng LB, Changlai SP, Shen YY, et al. (2003) Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterology 50:2154-2156
16. Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792-797
17. Oya N, Nagata Y, Tamaki N, et al. (1996) FDG-PET evaluation of therapeutic effects on VX2 liver tumor. J Nucl Med 37:296-302
18. Habermann RT, Williams FP Jr, Eyestone WH (1954) Spontaneous hepatomas in two woodchucks and a carcinoma of the testis in a badger. J Am Vet Med Assoc 125:295-298
19. Snyder R (1968) Hepatomas of captive woodchucks. Am J Pathol 52:32A-33A
20. Tennant BC, Toshkov IA, Peek SF, et al. (2004) Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 127:S283-S293
21. Goldberg BB, Liu JB, Burns PN, et al. (1993) Galactose-based intravenous sonographic contrast agent: Experimental studies. J Ultrasound Med 12:463-470
22. Forsberg F, Liu JB, Merton DA, et al. (1995) Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 14:949-957
23. Ohtomo K, Shiga J, Sasaki Y, et al. (1991) Iron oxide-enhanced MR imaging of hepatocellular carcinoma of woodchuck. Nippon Igaku Hoshasen Gakkai Zasshi 51:433-435
24. Qiu W, David D, Zhou B, et al. (2003) Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 162:1961-1974
25. Phelps ME, Huang SC, Hoffman EJ, et al. (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy- d -glucose: Validation of method. Ann Neurol 6:371-388
26. Muzic RF Jr, Cornelius S (2001) COMKAT: Compartment model kinetic analysis tool. J Nucl Med 42:636-645
27. Shibata T, Yamamoto K, Hayashi N, et al. (1988) Dynamic positron emission tomography with 13N-ammonia in liver tumors. Eur J Nucl Med 14:607-611
28. Lee JD, Yun M, Lee JM, et al. (2004) Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur J Nucl Med Mol Imaging 31:1621-1630
29. Trojan J, Schroeder O, Raedle J, et al. (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314-3319
30. Delbeke D, Martin WH, Sandler MP, et al. (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133:510-515; discussion 515-516
31. Torizuka T, Tamaki N, Inokuma T, et al. (1995) In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 36:1811-1817
32. Yu K, Schomisch SJ, Chandramouli V, et al. (2006) Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma. Comp Biochem Physiol C Pharmacol Toxicol 143:225-231